ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #2,194Hybrid

Stem Cells Translational Medicine

Acronym:stemcellstm
•
Abbreviation (ISO):STEM CELLS TRANSL. MED
•
Identifier (ISSN):2157-6564(Print)/2157-6580(Online)
•
Publisher:John Wiley and Sons Ltd
Clarivate IF (2026)
5.9↑ +1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Stem Cells Translational Medicine

WoS Q1
358104.9320185.9620196.4320206.9420217.662022620235.420244.920255.92026
Annual Impact Factor Metric
Current (2026):5.9
Scopus SJR & RankScopus Q1
1.588
#2,194

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
116

116 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation Rate1.9%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
96articles/year
99.59% Gold OA•70.75% Original Research

Aims & Scope

STEM CELLS Translational Medicine is a monthly, peer-reviewed, largely online, open access journal. STEM CELLS Translational Medicine works to advance the utilization of cells for clinical therapy. By bridging stem cell molecular and biological research and helping speed translations of emerging lab discoveries into clinical trials, STEM CELLS Translational Medicine will help move applications of these critical investigations closer to accepted best patient practices and ultimately improve outcomes. The journal encourages original research articles and concise reviews describing laboratory investigations of stem cells, including their characterization and manipulation, and the translation of their clinical aspects of from the bench to patient care. STEM CELLS Translational Medicine covers all aspects of translational cell studies, including bench research, first-in-human case studies, and relevant clinical trials.

Topics Covered (Recognized by AI)
BiologyGeneticsMedicineCell BiologyInternal MedicineChemistryBiochemistryStem CellsPathologyImmunologySurgeryCancer ResearchEndocrinologyPsychology
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

CELL & TISSUE ENGINEERING

Q1
Rank6/32
IndexSCIE
JCISCIE2026

CELL & TISSUE ENGINEERING

Q1
Rank7/32
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF5.9
Articles / Year46
Total Citations4
2025
IF4.9
Articles / Year88
Total Citations188
2024
IF5.4
Articles / Year130
Total Citations1,033
2023
IF6
Articles / Year128
Total Citations1,496
2022
IF7.655
Articles / Year147
Total Citations2,775

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,194Scopus Q1SCImago Profile
Scopus Coverage:2012-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
1.588

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
6.03

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,573 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,694
3-Year Documents274
Citable Documents269

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)2

Citations in government and international policy documents

Female Author Rate40.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Developmental BiologyQ1
Medicine (miscellaneous)Q1
Cell BiologyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 1.9%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区CELL & TISSUE ENGINEERING
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Stem Cells Translational Medicine (acronym: stemcellstm, abbr: STEM CELLS TRANSL. MED, ISSN: 2157-6564) is a peer-reviewed international scholarly journal in the field of CELL & TISSUE ENGINEERING, published by John Wiley and Sons Ltd in United States. The periodical holds a Journal Impact Factor (JIF) of 5.90, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.588 (Q1), an H-index of 116.

The journal enforces rigorous peer evaluation with an annual output of approximately 96 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,573 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
John Wiley and Sons Ltd
Publication Language
English
Frequency
Periodic
Indexing & Databases
SCIEScopusDOAJPubMed
Editorial Address
111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 27061a28-3207-4961-a5df-d0bed3a1f351
Database Updated: 2026-09-28